Sched.com Conference Mobile Apps
DIA Europe 2019
has ended
Create Your Own Event
Menu
Schedule
Speakers
Search
Log in
Sign up
DIA Europe 2019
-
Saved To
My Schedule
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
01 Stakeholders and Regulatory System Optimisation
All
Session
02 Evolution of Science and Policy
All
Session
03 Pharmacovigilance
All
Session
04 Modern Clinical Research
All
Session
05 Medical Affairs and Communication
All
Session
06 Access to Medicines
All
Session
07 Digital Disruptors
All
Session
08 Regional Updates
All
Session
Conference Closer
Content Hub
All
Session
DIAmond Sessions
All
Session
Executive Forum
All
Session
Hot Topics/Stand Alone
All
Session
ICH Info Day
All
Session
Keynote
All
Session
Leader of Tomorrow
All
Session
Networking
All
Social Event
Opening Plenary
All
Session
Poster Session
All
Session
Short Courses
All
Tutorial
Spotlight Sessions
All
Session
Women in Leadership
All
Session
Rustam Abdussalamov
National Center For Expertise of Medicines, Medical Devices and Medical Equipmen
Chief Development Officer
Virginia Acha
MSD, United Kingdom
Global Lead, Global Regulatory Policy
Mitzi Allred
Merck & Co., Inc., United States
Director, Clinical Operations
Susana Almeida
Medicines for Europe
Clinical Development and Safety Director
Hassaan S Alwohaibi
Saudi Food and Drug Authority
Executive Director of Regulatory Affairs Directorate
AA
Ana-Eva Ampelas
European Commission
Head of Unit, Medical products: Quality, Safety, Innovation
Charlotte Anderberg
Dental and Pharmaceutical Benefits Agency
Pharmaceutical Assessor
Artem Andrianov
Cyntegrity Germany GmbH
CEO
RA
René Anour
AGES
Senior Clinical Expert
Francis Arickx
National Institute for Health and Disability Insurance (RIZIV-INAMI)
Head of the Directorate Pharmaceutical Policy
Valdo Arnera
ERT
General Manager, Europe
CA
Carmen Arques
AZIERTA
Pharmacovigilance Manager
SA
Scott Askin
Novartis
Digital Solutions Director
Nadia Assenova
Sage Therapeutics
Head Regulatory Affairs Europe
Dimitrios Athanasiou
WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS
Patient Advocate
Susanne Ausborn
Hoffmann-La Roche Ltd
Regulatory Policy Lead
Peter Bachmann
Federal Institute for Drugs and Medical Devices (BfArM), Germany
Deputy-Head, European Union and International Affairs
Arton Baftiu
Norwegian Medicines Agency
Scientific Officer
DB
Dominic Balog-Way
King's College London
Research Associate
BB
Brendan Barnes
EFPIA
Director, Multilateral Issues and Health Policy
BB
Brendan Barnes
EFPIA
Director IP & Data Protection
WB
Walter Beck
Bayer AG
VP RD CO Head of Business Excellence & Innovation
Alun Bedding
Roche/Genentech
Director, Biostatistics
Nicola Bedlington
European Patient's Forum
Secretary General
Isabelle Bekeredjian-Ding
Paul-Ehrlich-Institut (PEI)
Head of Division of Microbiology
SB
Simon Bennett
Biogen
Director, EU Regulatory Policy
Conny Berlin
Novartis Pharma AG, Switzerland
Global Head, Quantitative Safety and Epidemiology
Cécile Bertin
F. Hoffmann La Roche LTD.
Associate Regulatory Program Manager
Trishna Bharadia
-
Patient Advocate, International Speaker, Writer, Advisor and Content...
KB
Kirstin Blackwell
Luto Research Ltd
Senior Manager
TB
Theo Blaise
Universite Claude Bernard Lyon
Pharmacy resident - Master degree
GB
Gerd Bode
Honorable Member of the Medical Faculty, Department of Pharmacology Toxicology
University of Goettingen
Peter Bogaert
Covington & Burling LLP
Partner
Claus Bolte
Swissmedic, Switzerland
Head of Authorisation
EB
Elena Bonfiglioli
Microsoft
Managing Director, Health and Life Sciences
WB
Wolfgang Bonitz
Novartis Pharma GmbH
Chief Scientific Officer
Gerrit Borchard
University of Geneva
Pedro Borga
Lifescience Dynamics Ltd
Consultant
FB
Frederic Bouder
University of Stavanger
Professor in Risk Management
Bruno Boulanger
PharmaLex
Chief Scientific Officer
Pascal Bouquet
Novartis
Global Head of Technology, Architecture and Digital for the Drug...
Carmen Bozic
Biogen
SVP, Portfolio Transformation
NB
Nihan Burul Bozkurt
Turkish Medicines and Medical Devices Agency (TITCK)
Head of the Clinical Trials Department
Romuald Braun
AMPLEXOR Life Sciences
Vice President, Strategy - Life Sciences
Karl Broich
Federal Institute for Drugs and Medical Devices (BfArM), Germany
President
Marloes van Bruggen
F.Hoffmann-La Roche Ltd.
Regional Regulatory Policy Lead
Marieke De Bruin
Copenhagen University
Director, Copenhagen Centre for Regulatory Science
Nikolai Brun
Danish Medicines Agency, Denmark
Co-Chair, EMA-MHA Big Data Task Force; Dir, Div for Medical Eval...
Philippe De Buck
FAGG-AFMPS
Head of Authorisations
Jennifer Burgess
TransCelerate BioPharma, Inc., United States
Vice President, Global Engagement and Communications
Andy Bushell
Oonida
CEO, OoNiDa
Bill Byrom
Signant Health
Vice President, Product Strategy and Innovation
Jorge Camarero
Spanish Agency For Medicines
CHMP Alternate
FC
Fiona Carlin
Baker McKenzie
Partner
Tania Cecilia Cavaliero
Swissmedic
Preclinical Assessor
HC
Hacer Coskun Cetintas
Turkish Medicines and Medical Devices Agency (TITCK)
Head of the Medicines Marketing Authorization Department
JC
Jianqing Chang
Tigermed Consulting Ltd., China
Vice President, Drug Regulatory Policy
Inas Chehimi
Novartis Pharma Services AG
Head DRA Middle East & North Africa
MC
Magda Chlebus
EFPIA
Executive Director Science Policy & Regulatory Affairs
Disa Lee Choun
UCB Celltech
Head of Innovation, Global Clinical Services and Operations
Klaus Cichutek
Paul-Ehrlich-Institut
President
Ingeborg Cil
Shire Now Part of Takeda
Lead, Clinical Trial Data Anonymization
DC
Douglas Clark
NA
Scott Cleve
Boehringer Ingelheim
Head of Global Regulatory Operations
EC
Eric Cohen
Abbvie
Medical Director
Evi Cohen
Appian
Vice President, Global Life Sciences & Healthcare
Emer Cooke
World Health Organization (WHO)
Director of Regulation of Medicines and other Health Technologies
Matt Cooper
NIHR Clinical Research Network
Business Development and Marketing Director
Sophie Cooper
National Institute for Health and Care Excellence (NICE)
Scientific Adviser
Solange Corriol-Rohou
AstraZeneca
Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
Amelia Cupelli
AIFA
Senior Pharmacovigilance Assessor, PRAC member
KC
Kosta Cvijovic
Syneos Health
EU QPPV
Gaby Danan
NA
Pharmacovigilance Expert
Jessica Davies
F. Hoffmann-La Roche Ltd
Senior Data Scientist, RWD Collaborations
Richard Davies
CluePoints
Vice President, Solution Expert
Dave deBronkart
e-Patient Dave
Speaker
Laurent Desqueper
MSD Europe
XEVMPD-IDMP Regional Business Lead
Petra Doerr
Swissmedic
Deputy Executive Director
Sreemanee Dorajoo
Health Sciences Authority, Singapore
Data Analyst
Jennifer Doralt
Shire, Now Part of Takeda
Lead Medical Writer - Hematology/Oncology
Dinah Duarte
INFARMED, Portugal
Scientific Evaluation Unit, Directorate of Medicinal Products
João Duarte
Alexion, Astrazeneca Rare Disease, France
Director, Business Planning & Operations, Global Regulatory...
James Duhig
AbbVie, Inc.
Director, Patient Integration
Francoise Dumas-Sillan
Pfizer Italy
EU QPPV
Brian Edwards
NDA Group, United Kingdom
Principal Consultant, Pharmacovigilance and Drug Safety,...
LE
Lindsay Edwards
GSK
Vicki Edwards
AbbVie, Inc., United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
Kristel Van der Elst
The Global Foresight Group
CEO
Menno Van Der Elst
Medicines Evaluation Board
PRAC member
Harald Enzmann
Federal Institute for Drugs and Medical Devices (BfArM)
Chair, CHMP; Head of European and International Affairs
Sini Eskola
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Director Regulatory Affairs
Rocco Falchetto
International Porphyria Patient Network
President
AF
Alex Farrell
TransPerfect
Regional Director Business Development
Jane Feron
AstraZeneca UK Ltd
Risk Management Director
PF
Pisana Ferrari
PHA Europe, European Pulmonary Hypertension Assoc.
Vice President
LF
Lisa Ferstenberg
AstraZenca
Principal Patient Safety Physcian
RF
Reinhard Fescharek
CSL Behring GbmH
Vice President
Chrissie Fletcher
Amgen Ltd
Executive Director, Biostatistics in Global Biostatistical Science
Frederik Floether
IBM
IBM Q Consulting Global Life Sciences Leader, Quantum & AI
Michael Forstner
PrimeVigilance
Senior Vice President, Head of Risk Management and...
MF
Miguel Forte
Miguel Forte
Chief Executive Officer
Emma Du Four
Abbvie
Head of International Regulatory Policy
Shelley Gandhi
NDA Group
Strategic Advisor, Pharmacovigilance and Drug Safety
UG
Ursula Garczarek
Cytel
Associate Director, Strategic Consulting
Marie Gardmark
Swedish Medicines Agency (MPA), Sweden
Head of Licensing
ZG
Zoe Garrett
National Institute for Health and Care Excellence (NICE)
SeniorTechnical Adviser – EUnetHTA
Patrick Gassenbauer
MSD Sharp & Dohme GmbH
QA Specialist
Jan Geissler
Patvocates
CEO
PG
Peter Gocke
Charité Berlin
Chief Digital Officer
Wim Goettsch
Dutch National Health Care Institute (ZIN)
Special Advisor HTA
Kate Gofman
Astrazeneca
Safety Physician
Martim Goncalves
IQVIA
Global Solutions Manager (R&D)
RG
Ravi Gopalakrishnan
AstraZeneca
Head of Digital Platform and Applications
Dmitriy Goryachev
Center of Expertise and Quality Control of Medicinal Products, Moh Russian Feder
Director
AG
Amelie Goyer
Nestec Ltd.
Clinical Project Manager
Marco Greco
European Patients’ Forum, Belgium
President
Michelle Grimes
Merck and Co., Inc., Denmark
Head, International Pharmacovigilance. GCS&PV
Irena Guzina
HAS
Scientific Project manager
David Haerry
European AIDS Treatment Group
Member
Ian Hamilton
Eli Lilly and Company
Medical Affairs Global IT Account Manager
Elizabeth Hancox
GSK
Deputy QPPV and Head of Safety Governance
Michael Happich
Eli Lilly
HTA director
Florent Hartmann
Novartis Pharma AG
Regulatory Sub-Region Head
Sabine Haubenreisser
European Medicines Agency, Netherlands
Principal Scientific Administrator, Stakeholders and Communication...
Annemarie Haverhals
Independent Consultant On VBHC
Adam Heathfield
Pfizer
Senior Director, Patient and Health Impact
Niklas Hedberg
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
Chair EUnetHTA Executive Board; Chief Pharmacist
LH
Lisa Hedman
World Health Organisation
CH
Clara Heering
Johnson & Johnson
Enterprise JJCO lead for Capacity & Alliance Management
Esa Heinonen
Finnish Medicines Agency (Fimea)
Director, Assessment of Medicinal Products
Bruce Hellman
uMotif
CEO and Co-founder
Robert Hemmings
Medicines and Healthcare products Regulatory Agency (MHRA)
Statistics and Pharmacokinetics Unit Manager
EH
Esteban Herrero-Martinez
Abbvie Ltd
Director Regulatory Policy and Intelligence
TH
Tuyen Ho
Welocalize Life Sciences
VP of Market and Corporate Development
MH
Mike Holmes
MSD
Associate Vice President, Global Medical Affairs Oncology
Benjamin Horbach
F. Hoffmann-La Roche
François Houyez
European Organisation for Rare Diseases (EURODIS), France
Information and Access Director, Health Policy Advisor
Kenneth Hu
Rutgers University/Ernest Mario School of Pharmacy
Postdoctoral Fellow
Ian Hudson
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Chief Executive
KH
Karl-Heinz Huemer
Austrian Medicines and Medical Devices Agency (AGES)
Clinical Assessor, Scientific Office
Wendy Huisman
Vigifit, Netherlands
Director
Anthony Humphreys
European Medicines Agency (EMA)
Head of Scientific Committees Regulatory Science Strategy
Berthold Huppertz
Medical University of Graz
Chair, Division of Cell Biology, Histology and Embryology
Hugo Hurts
Medicines Evaluation Board (MEB)
Chair HMA Task Force; Executive Director
Simon Ingate
Huron Consulting Group
Director
Malin Jakobsson
Uppsala Monitoring Centre
Product Strategy Manager
Merete Joergensen
Novo Nordisk A/S
Senior Trial Disclosure Director, Global Clinical Registry
Angelika Joos
Merck Sharp & Dohme (Europe) Inc., Belgium
Executive Director, Global Regulatory Policy
Greg Jordinson
Janssen R&D
Associate Director, Global Regulatory Affairs
EJ
Etienne Jousseaume
Novartis
Head Market Access Cell and Gene Europe
LK
Lindsay Kadjidja
Institut De Pharmacie Industrielle De Lyon
Student
CK
Chitkala Kalidas
Bayer
VP and Head Oncology Regulatory Affairs
OK
Oksana Karavaeva
IPHARMA LLC
ClinOps Director
Srinivas Karri
Oracle Corporation
Senior Director, Clinical Warehousing Cloud Strategy
MK
Maureen Kenny
Informa
EXECUTIVE EDITOR
RK
Ryan Kilpatrick
AbbVie
Global Head, Epidemiology
DK
Diane Kleinermans
Ministry of Health and Social Affairs
Advisor
MK
Manfred Koehler
Koehler eClinical GmbH
CEO
Beata Kolon
ICON
Director Medical Safety Services
Hideyuki Kondo
Pharmaceuticals and Medical Devices Agency (PMDA)
Deputy Director, Office of International Program
Tatsuya Kondo
Pharmaceuticals and Medical Devices Agency (PMDA)
Chief Executive
Wolfgang Kothny
Novartis Pharma, Switzerland
Global Head Clinical Sciences
Oguzhan Koyuncu
Turkish Medicines and Medical Devices Agency (TITCK)
Advisor to the President
Jürgen Kübler
QSciCon
Owner
Thomas Kühler
Sanofi R&D, France
Head GRSP EU/AMEE
LK
Lembe Kullamaa
European Patients' Forum
Representative Estonian Chamber of Disabled People at EPF Youth Group
Barbara Lopez Kunz
DIA, United States
Global Chief Executive
Sandra Kweder
FDA, United States
Deputy Director, Europe Office, Office of Global Programs and...
Julia Lakeland
Parexel, United Kingdom
Senior Director,Sensor Solutions
LL
Linda Landells
National Institute for Health and Care Excellence (NICE)
Associate Director Technology Appraisals (Cancer Drugs Fund)
Niels Leander
NNIT
Consulting Director
AL
Adelina Lear
ICON plc
Strategic Account Executive
Hans Lehrach
Max Planck Institute for Molecular Genetics
Director
EJ
Evert Jan van Lente
AOK Bundesverband (Federal Insurer)
Director EU-Affairs
IL
Iain Leslie
F. Hoffmann-La Roche
Health Outcomes Manager, Communications, Policy and Access Directorate
Hubert Leufkens
Utrecht University
Professor, Pharmaceutical Policy and Regulatory Science
David Lewis
Novartis Pharma AG, Switzerland
Head QPPV PRRC Office, Chief Medical Office & Patient Safety
Beatriz Silva Lima
NDA Advisory Services Limited
Professor of Pharmacology; NDA Advisory Board
Mika Lindroos
Signant Health
Director, Product Management, eConsent
Lenita Lindström-Gommers
European Commission
ICH Assembly Chair and Senior Expert, European Commission
Rory Littlebury
Medicines and Healthcare products Regulatory Agency (MHRA)
Pharmacovigilance Inspector
JL
Johan Liwing
Janssen
Director Market Access RWE Partnerships, Global Commercial Strategy...
RL
Ragnar Lofstedt
Kings College London
Professor of Risk Management
Murray Lumpkin
Bill and Melinda Gates Foundation, United States
Deputy Director, Integrated Development, Lead for Global Reg Systems...
Gavin Lyndon
Pfizer
Global Lead, Content Strategy and Management – Medical Information
Judith Macdonald
Pfizer
Head of Global Regulatory Policy & Intelligence
Souzi Makri
Cyprus League Against Rheumatism
Vice-President
Marie Manley
Sidley Austin LLP, United Kingdom
Partner, Head of EU and UK Life Sciences (UK)
SM
Susan Manoff
MSD
Executive Director
Friedrich Maritsch
Shire Now Part of Takeda
Data Anonymization Lead
David Martin
FDA
Associate Director for Real World Evidence Analytics, OMP, CDER
Agnes Mathieu-Mendes
European Commission
Deputy Head of Unit
MM
Matthew May
EUPATI
Programme Coordinator, EUPATI Project
CM
Christine Mayer-Nicolai
EMD Serono
Global Head, Global Regulatory and Scientific Policy
AM
Amy McKee
FDA
Deputy Director FDA/Oncology Center of Excellence
NM
Nick Meade
Genetic Alliance UK
Director of Policy
Suzanne Meenan
Roche Products Ltd, UK, United Kingdom
Medical Information Group Lead
DM
Daniela Melchiorri
University of Roma
Member CHMP
CM
Camille Metais
Alexion Pharma GmbH
Senior Director Regulatory Affairs
Thomas Metcalfe
F. Hoffmann-La Roche
Data Policy Leader, Personalised Healthcare
1
2